Skip to content
| Characteristics |
Pilot study
Peer reviewed
|
| Topics |
MDMA
PTSD
|
Abstract
Current treatments for chronic post-traumatic stress disorder (PTSD) have limited efficacy. In a two-stage, phase 2 study (funded by a nonprofit
Related reading
-
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Psychopharmacology
September 1, 2019
364 citations
-
MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway
European Psychiatry
June 1, 2022
-
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Journal of Psychopharmacology
October 31, 2012
407 citations
-
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Nature Medicine
June 1, 2021
965 citations
-
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
FOCUS: The Journal of Lifelong Learning in Psychiatry
July 1, 2023
97 citations
Explore topics
By condition and practice